RT @RichardPAConway: Aggarwal @docrota et al. TYK2/JAK1i brepoctinib in dermatomyositis. Supportive clinical and pharmac

Social Author Image
https://pbs.twimg.com/profile_images/1389468430160510976/sooz0Ud3.jpg
Tweet Author
RichardPAConway
Social Author Name
Richard Conway
Tweet Content
Aggarwal @docrota et al. TYK2/JAK1i brepoctinib in dermatomyositis. Supportive clinical and pharmacological evidence, plus efficacy of other JAK agents, likely to lead to a clinical trial. @rheumnow #ACR22 Abstr#0157 https://t.co/Tz6dHfyUmq https://t.co/0R0tcuCe6D
Links
Brepocitinib for the Treatment of Dermatomyositis: Pharmacologic and Clinical R… https://acrabstracts.org/abstract/brepocitinib-for-the-treatment-of-dermatomyos…
Show on Archive Page
On
Display in Search Results
On
PDQ
Off
×